Is $SPRY pump-proof?

ARS Pharmaceuticals, Inc.: trap-risk read from social crowding, price extension, and SEC disclosure flags. Updated 2026-09-07.

$SPRY
ARS Pharmaceuticals, Inc.
CLEAR RISK
9
/ 100 trap score
Boring, in the best way. No run-up, no crowding, and a clean recent filing history.
Hype / crowding
13
Run-up / extension
5
Structural risk
10
~Automatic shelf (S-3ASR) on file 1.6 years ago: routine for large issuers (often debt), low dilution signal [S-3ASR 2025-01-31]↗
🔒 1 more filing flagged on $SPRY: see all of them free.
All 2 flags + filing links, free. No spam, unsubscribe anytime.
PumpProof · pumpproof.com
as of 2026-09-07 · not financial advice
What these filings mean
What a shelf registration is →How share dilution works →All the filing explainers →
Check any other ticker free at pumpproof.com

Get the Sunday watchlist before Monday's open

Every Sunday evening: the names heating up on weekend chatter before they hit this board, scored against their filings. Plus Friday receipts: how every score aged, wins and misses. Free, in your inbox.